Literature DB >> 7507895

Modulation of cell surface-associated mannoprotein antigen expression in experimental candidal vaginitis.

F De Bernardis1, A Molinari, M Boccanera, A Stringaro, R Robert, J M Senet, G Arancia, A Cassone.   

Abstract

The monoclonal antibody (MAb) AF1 recognizes an oligosaccharide epitope present on highly immunogenic and immunomodulatory mannoproteins (MP) of Candida albicans. The expression of this epitope (AF1-MP) during experimental candidal vaginitis was studied in two strains of C. albicans (3153 and CA-2) which were equally vaginopathic but differed in the mode of hypha formation in the vagina. In both strains, immunofluorescence of vaginal samples, taken 1 h after challenge, revealed an intense, MAb AF1-specific labelling of the yeast cells. This labelling was very scarce in fungal cells taken at 24 h and on subsequent days during the development of filamentous forms. Electron-microscopic gold immunolabelling observations showed that molecules carrying AF1-MP spanned the entire cell wall in the initial yeast cells but were absent on the cell surface and in the outermost, capsular layer of the cell wall of the germ tubes and filamentous forms. In both strains, at any time and for any form of intravaginal growth, AF1-MP was clearly expressed in the cytoplasm and cytoplasmic vesicles, and was fully incorporated into the inner layers of the cell wall. As seen by immunofluorescence, the vaginal fluid from C. albicans-infected rats did not hinder the expression of AF1-MP on the yeast cells surface in vitro. In electron-microscopic gold immunolabelling, a hypha-specific MAb (3D9) labelled the surface of the hyphal but not of the yeast cells of C. albicans harvested from rat vagina. Overall, these data strongly suggest that cell surface expression of MP antigen is modulated during intravaginal growth and morphogenesis of C. albicans.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507895      PMCID: PMC186136          DOI: 10.1128/iai.62.2.509-519.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Fab fragments from a monoclonal antibody against a germ tube mannoprotein block the yeast-to-mycelium transition in Candida albicans.

Authors:  M Casanova; J P Martínez; W L Chaffin
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

2.  Dynamic changes of the cell wall surface of Candida albicans associated with germination and adherence.

Authors:  G Tronchin; J P Bouchara; R Robert
Journal:  Eur J Cell Biol       Date:  1989-12       Impact factor: 4.492

3.  Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis.

Authors:  F De Bernardis; L Agatensi; I K Ross; G W Emerson; R Lorenzini; P A Sullivan; A Cassone
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

4.  Differences in the antigenic expression of immunomodulatory mannoprotein constituents on yeast and mycelial forms of Candida albicans.

Authors:  A Torosantucci; M Boccanera; I Casalinuovo; G Pellegrini; A Cassone
Journal:  J Gen Microbiol       Date:  1990-07

5.  Lymphoproliferative and cytotoxic responses of human peripheral blood mononuclear cells to mannoprotein constituents of Candida albicans.

Authors:  A Torosantucci; C Palma; M Boccanera; C M Ausiello; G C Spagnoli; A Cassone
Journal:  J Gen Microbiol       Date:  1990-11

6.  Enzymatic release of germ tube-specific antigens from cell walls of Candida albicans.

Authors:  P M Sundstrom; G E Kenny
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

7.  Genetic evidence for role of extracellular proteinase in virulence of Candida albicans.

Authors:  K J Kwon-Chung; D Lehman; C Good; P T Magee
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

Review 8.  Antigenic variability of Candida albicans.

Authors:  D Poulain; V Hopwood; A Vernes
Journal:  Crit Rev Microbiol       Date:  1985       Impact factor: 7.624

Review 9.  Cleavage of immunoglobulins by pathogenic yeasts of the genus Candida.

Authors:  R Rüchel
Journal:  Microbiol Sci       Date:  1986-10

10.  Experimental chronic vaginal candidosis in rats.

Authors:  J D Sobel; G Muller; J F McCormick
Journal:  Sabouraudia       Date:  1985-06
View more
  19 in total

1.  Biochemical and immunological characterization of MP65, a major mannoprotein antigen of the opportunistic human pathogen Candida albicans.

Authors:  M J Gomez; B Maras; A Barca; R La Valle; D Barra; A Cassone
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 2.  Anticandidal immunity and vaginitis: novel opportunities for immune intervention.

Authors:  Antonio Cassone; Flavia De Bernardis; Giorgio Santoni
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

3.  MP1 encodes an abundant and highly antigenic cell wall mannoprotein in the pathogenic fungus Penicillium marneffei.

Authors:  L Cao; C M Chan; C Lee; S S Wong; K Y Yuen
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

4.  Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats.

Authors:  F De Bernardis; M Boccanera; D Adriani; E Spreghini; G Santoni; A Cassone
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

Review 5.  Serologic response to cell wall mannoproteins and proteins of Candida albicans.

Authors:  J P Martínez; M L Gil; J L López-Ribot; W L Chaffin
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

6.  Noninhibitory binding of human interleukin-2-activated natural killer cells to the germ tube forms of Candida albicans.

Authors:  G Arancia; A Molinari; P Crateri; A Stringaro; C Ramoni; M L Dupuis; M J Gomez; A Torosantucci; A Cassone
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

7.  Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.

Authors:  Carla Bromuro; Antonella Torosantucci; Paola Chiani; Stefania Conti; Luciano Polonelli; Antonio Cassone
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

Review 8.  Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans.

Authors:  P L Fidel; J A Vazquez; J D Sobel
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

9.  Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis.

Authors:  F De Bernardis; A Cassone; J Sturtevant; R Calderone
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

10.  Candida albicans yeast and germ tube forms interfere differently with human monocyte differentiation into dendritic cells: a novel dimorphism-dependent mechanism to escape the host's immune response.

Authors:  Antonella Torosantucci; Giulia Romagnoli; Paola Chiani; Annarita Stringaro; Pasqualina Crateri; Sabrina Mariotti; Raffaela Teloni; Giuseppe Arancia; Antonio Cassone; Roberto Nisini
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.